To Evaluate the Impact of Consumption of a Bioactive Compound on Fasting Blood Glucose Levels in Asian Indians With Pre-diabetes

NARecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 22, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

October 30, 2024

Conditions
PreDiabetes
Interventions
DIETARY_SUPPLEMENT

N-trans-caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT)

N-trans-caffeoyltyramine (NCT) and N-trans-feruloyltyramine (NFT) derived via synthetic biology (i.e., fermentation using a recombinant microorganism) to provide a high purity (\>85%) form of these compounds that are structurally identical to their naturally occurring counterparts. All ingredients in the encapsulated final test article, including the NCT and NFT, are manufactured under food GMPs and are of suitable quality for use in food, dietary supplements, and specialty nutrition products.

DIETARY_SUPPLEMENT

Placebo Control

Placebo Control

Trial Locations (1)

110 016

RECRUITING

Diabetes Foundation (India), New Delhi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brightseed

INDUSTRY